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Belgian GBS Key Steps
 1985, A thesis at University of Liege
 1985-1994 Several local studies
 Since 1995, Belgian GBS reference laboratory
 1998-2000, Regional surveys and multi-centric 
studies
 2001, “Consensus” meeting
 End 2001, “Guidelines” by Belgian Associations of 
Gynecologists and Obstetricians
 June 2002, Working group appointed by Ministry 
of Health
 End 2002, Expected launch of Belgian guidelines 
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BELGIUM
In 1999
Total population : 10 213 752
Births : 114 276
> 65 years : 1 697 453
INS, Ministère des affaires économiques, 2000
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Belgian Epidemiology
Occurrence of pathogens in neonatal (0-28 D) 
septicemia and meningitis (ISP Lab.Network)
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Neonatal GBS Early Onset Disease
Belgian Background in 2001
 1999-2001, EOD:LOD = 4:1
Meningitis : 10 %
Mortality > 14 %
 Incidence
1985: 3/1000 live births
1990: 3/1000 live births + 4/1000 likely cases
1999, estimated : 2/1000
 60 % EOD had NO maternal risk factor
 Prenatal screening, vagina/rectum : 13-25 %
P.Melin, reference laboratory for GBS.
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Prevention of neonatal GBS EOD 
From where are we coming ?
2 mail surveys:
 French Community, 
1998-1999
P.Melin, 40th ICAAC, #1746, 
2000
 Flemish Community, 
1999
L.Mahieu, 2000, J Obst Gyn; 
5:460-4
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Practices Related to Prevention of 
Neonatal GBS EOD
 Objective of surveys: to measure “GBS” practices
 Evaluation by comparison to CDC 1996 guidelines
 As baseline before national expert consensus guidelines
 Design
 Setting
 French Community(Fr) and Flemish Community (Fl)  
 Participants  
 All obstetric departments supervisors (Fr), all obstetricians (Fl 
and Fr) and all microbiologists (Fr) 
 Mail survey,November 1998-March 1999
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Practices related to Prevention of 
Neonatal GBS EOD in Belgium
 Questions related to
 Demographic data
 Knowledge of neonatal GBS disease
 Attitudes and practices related to screening and 
intrapartum prophylaxis 
 Swabs, timing, proportion of women screened, RF, IAP (who, 
timing, regimen), laboratory processing
 Main outcome
 Proportion of hospital policy and individual practice 
according CDC 1996 guidelines
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Obstetricians’ Compliance with 
CDC guidelines - Approaches
90
58
91 94
44
36 36
57
0
10
20
30
40
50
60
70
80
90
100
Screening-
based
Preterm ROM>18h Fever
%
 
O
b
s
t
e
t
r
i
c
i
a
n
s
French C. Flemish C.
pm-chu lg 02
10
Obstetricians’ Compliance with 
CDC guidelines - Screening
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Compliance with CDC guidelines
 Intrapartum antibioprophylaxis:
 Penicillin as first choice ~ 20 %
 Dosage and schedule : frequently inadequate
 In Northern Belgium : 15 % oral route
 Prenatal screening : 
 Rarely use of selective broth
 Geographical differences
 OB with < 10 years practice : the bests
 Hospital policy (Fr.C), total agreement : 30%
 Lack of partners’ coordination
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 Invited attendance:
 Obstetricians
 Neonatologists
 Medical microbiologists
 Infectious disease specialists
 Foreign invited speakers:
 S.Schrag, CDC, USA
 D.Davies, Calgary, Canada
 B.Brodeur, Laval, Canada
 M. de la Rosa, Granada, Spain
 Supported by professional 
associations
Perinatal Group B 
Streptococcal Diseases
Towards a Belgian Consensus
November 17, 2001
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“Towards a Belgian consensus” - Program
 Worldwide and Belgian GBS burden
 Guidelines for prevention
 Comparative cost-effectiveness of different
approaches
 Successes and adverse effects
 Management of neonates with risk factors for 
GBS disease
 Microbiology, logistic and special problems
 Vaccine perspective
 Belgian survey
 Interactive session
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“Towards a Belgian consensus”
Interactive session
Voting and discussion panel
Demographic data
Data about their current policy
To reach a consensus
Cut-off ≥ 80 % of agreement
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 Support for universal prenatal GBS 
screening-based approach : 93 %
 Support for Penicillin G as the 1st 
choice : 92 %
 Integration of selective postnatal 
antibioprophylaxis for neonates at 
high risk : 79 %
 Ready for an intrapartum rapid 
screening-based approach when 
available : 47 %  
Perinatal Group B 
Streptococcal Diseases
Towards a Belgian consensus
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“Towards a Belgian consensus”
Follow-up
Belgian Ministry of Health
A GBS working group appointed
Drafting of recommendations for the 
prevention of perinatal GBS disease
Expected deadline : end 2002
European workshop 
GBS neonatal disease prevention, 
Granada, November 2002    
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Co-organizers of “Consensus”
meeting
Gerda Verschraegen, Univ. Gent
Ludo Mahieu, Univ. Antwerpen
Geert Claeys, Univ. Gent
Collaborators, Univ. Liege
Jean-Michel Foidart
Patrick De Mol
Myriam Schmitz
Isabelle Heinrichs
Belgian Challenge = 
To prevent annually > 200 cases 
of neonatal GBS EOD
